Connect with us

Hi, what are you looking for?

Tuesday, Dec 7, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Organigram shares rise on 22% revenue boost

The firm’s new CEO looks to be off to a strong start

Organigram shares rise on 22% revenue boost
Image via Organigram

Canadian producer Organigram Holdings Inc. (TSX: OGI) is seeing a jump in its stock price, as the firm reports its brands are carving out more market share and boosting income.

On Tuesday, the company released its earnings results for the three months ended Aug. 31, with sales climbing 24 per cent to $36.2 million.

Organigram said it achieved 7 per cent of the recreational cannabis market, up from 5.4 per cent in the previous quarter, putting it at the number-four spot in the country. It reported its share increasing since then to 7.9 per cent as of October.

Net revenue rose 22 per cent to $24.9 million, from $20.3 million last quarter. Recreational net revenue hit $22.9 million, up 36 per cent.

Adjusted earnings before interest, taxes, depreciation and amortization improved by 53 per cent to negative $4.8 million, from negative $10.2 million.

But net loss increased 550 per cent in the period to $26 million, from $4 million, which the firm said was due to impairment charges.

The company ended the quarter with $183.6 million in cash and short-term investments, as well as $300,000 in debt.

Company stock rose almost 9 per cent Tuesday to $2.58 on the Toronto Stock Exchange.

During the quarter, Organigram launched 16 new products on the recreational market — including Edison Jolts, an ingestible lozenge, and Shred’ems, an infused gummy.

The firm also boasted that its Shred pre-milled weed was the number-one most searched brand on the Ontario Cannabis Store website for 11 out of the past 12 months.

Organigram’s results show its momentum in leading innovation and increasing efficiencies, says CEO Beena Goldenberg.

“We are particularly pleased with our market share gains in the quarter to become a number-four LP and will build on these successes into fiscal 2022,” she said in a statement.

In May, former CEO Greg Engel stepped down from. In August, he was replaced by Goldenberg, former president and CEO of The Supreme Cannabis Company.

Read more: Organigram drops CEO shortly after big tobacco investment

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe